West Pharmaceutical Services (WST) Current Deferred Tax Assets (2009 - 2015)

West Pharmaceutical Services' Current Deferred Tax Assets history runs 7 years deep, the most recent figure standing at $8.3 million for Q3 2015.

• In Q3 2015, Current Deferred Tax Assets fell 54.89% year-over-year to $8.3 million; the TTM figure through Sep 2015 stood at $8.3 million (down 54.89% YoY), while the FY2014 annual figure was $7.8 million, down 50.94% from the prior year.
• Current Deferred Tax Assets came in at $8.3 million for Q3 2015 at West Pharmaceutical Services, up from $8.2 million in the prior quarter.
• In the past five years, Current Deferred Tax Assets ranged from a high of $18.4 million in Q3 2014 to a low of $7.4 million in Q2 2012.
• A 5-year average of $10.7 million and a median of $9.1 million in 2013 frame the typical range for Current Deferred Tax Assets.
• Across the five-year window, Current Deferred Tax Assets jumped 106.49% in 2013 and plunged 54.89% in 2015, its largest moves.
• West Pharmaceutical Services' Current Deferred Tax Assets stood at $7.9 million in 2011, then decreased by 2.53% to $7.7 million in 2012, then soared by 106.49% to $15.9 million in 2013, then slumped by 50.94% to $7.8 million in 2014, then increased by 6.41% to $8.3 million in 2015.
• According to Business Quant data, Current Deferred Tax Assets over the past three periods registered $8.3 million, $8.2 million, and $8.7 million for Q3 2015, Q2 2015, and Q1 2015 respectively.

Peer Comparison